Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results (Q47175930)
Jump to navigation
Jump to search
scientific article published on 20 November 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results |
scientific article published on 20 November 2017 |
Statements
1 reference
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results (English)
1 reference
Keith Flaherty
1 reference
Eileen M O'Reilly
1 reference
James Roach
1 reference
Paul Miller
1 reference
Kenneth H Yu
1 reference
Catherine Tjan
1 reference
Molly Rosano
1 reference
Silva Krause
1 reference
William Avery
1 reference
Julie Wolf
1 reference
Darrell Nix
1 reference
David P Ryan
1 reference
20 November 2017
1 reference
1 reference
22
1 reference
12
1 reference
1429-e139
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference